Role of epigenetic mechanisms in epithelial-to-mesenchymal transition of breast cancer cells

Translational Research

Volumn 165, Issue 1, 2015, Pages 126-142

  Nickel, Annina ^a,b   Stadler, Sonja C ^a,b  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; UNTRANSLATED RNA; HISTONE;

BREAST CANCER; CANCER CELL; CHROMATIN ASSEMBLY AND DISASSEMBLY; DEREGULATION; DNA METHYLATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; HISTONE MODIFICATION; HUMAN; MACHINE; NUCLEOSOME; PROTEIN EXPRESSION; REVIEW; TUMOR GROWTH; ANIMAL; BREAST NEOPLASMS; FEMALE; GENETIC EPIGENESIS; GENETICS; METABOLISM; MOUSE; PATHOLOGY; TRANSLATIONAL RESEARCH;

ANIMALS; BREAST NEOPLASMS; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA METHYLATION; EPIGENESIS, GENETIC; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HISTONES; HUMANS; MICE; RNA, UNTRANSLATED; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84919868497     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2014.04.001     Document Type: Review

References (255)

1. C. DeSantis, R. Siegel, P. Bandi, and A. Jemal Breast cancer statistics, 2011 CA Cancer J Clin 61 2011 409 418
2. G.P. Gupta, and J. Massagué Cancer metastasis: building a framework Cell 127 2006 679 695
3. M. Yilmaz, and G. Christofori EMT, the cytoskeleton, and cancer cell invasion Cancer Metas Rev 28 2009 15 33
4. S. Valastyan, and R.A. Weinberg Tumor metastasis: molecular insights and evolving paradigms Cell 147 2011 275 292
5. J.P. Thiery Epithelial-mesenchymal transitions in development and pathologies Curr Opin Cell Biol 15 2003 740 746
6. J.P. Thiery, H. Acloque, Ruby Y. Huang, and M.A. Nieto Epithelial-mesenchymal transitions in development and disease Cell 139 2009 871 890
7. G. Berx, E. Raspé, G. Christofori, J.P. Thiery, and J.P. Sleeman Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer Clin Exp Metas 24 2007 587 597
8. P. Martin Wound healing: aiming for perfect skin regeneration Science 276 1997 75 81
9. R. Kalluri, and E.G. Neilson Epithelial-mesenchymal transition and its implications for fibrosis J Clin Invest 112 2003 1776 1784
10. C.L. Chaffer, E.W. Thompson, and E.D. Williams Mesenchymal to epithelial transition in development and disease Cells Tissues Organs 185 2007 7 19
11. K. Polyak, and R.A. Weinberg Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits Nat Rev Cancer 9 2009 265 273
12. J.H. Tsai, J.L. Donaher, D.A. Murphy, S. Chau, and J. Yang Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis Cancer Cell 22 2012 725 736
13. O.H. Ocaña, R. Córcoles, and A. Fabra Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1 Cancer Cell 22 2012 709 724
14. W.L. Tam, and R.A. Weinberg The epigenetics of epithelial-mesenchymal plasticity in cancer Nat Med 19 2013 1438 1449
15. S.A. Mani, J. Yang, and M. Brooks Mesenchyme forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers Proc Natl Acad Sci U S A 104 2007 10069 10074
16. C. Scheel, and R.A. Weinberg Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links Semin Cancer Biol 22 2012 396 403
17. S.A. Mani, W. Guo, and M. Liao The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 2008 704 715
18. A. Morel, M. Lièvre, C. Thomas, G. Hinkal, S. Ansieau, and A. Puisieux Generation of breast cancer stem cells through epithelial-mesenchymal transition PLoS One 3 2008 e2888
19. M. Shipitsin, L.L. Campbell, and P. Argani Molecular definition of breast tumor heterogeneity Cancer Cell 11 2007 259 273
20. C. Sheridan, H. Kishimoto, and R.K. Fuchs CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis Breast Cancer Res 8 2006 R59
21. D. Sarrió, S.M. Rodriguez-Pinilla, D. Hardisson, A. Cano, G. Moreno-Bueno, and J. Palacios Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype Cancer Res 68 2008 989 997
22. C.M. Perou, T. Sørlie, and M.B. Eisen Molecular portraits of human breast tumours Nature 406 2000 747 752
23. T. Sørlie, C.M. Perou, and R. Tibshirani Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 98 2001 10869 10874
24. G. Honeth, P. Bendahl, and M. Ringnér The CD44+/CD24- phenotype is enriched in basal-like breast tumors Breast Cancer Res 10 2008 R53
25. T. Brabletz, A. Jung, and S. Reu Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment Proc Natl Acad Sci U S A 98 2001 10356 10361
26. T. Brabletz To differentiate or not: routes towards metastasis Nat Rev Cancer 12 2012 425 436
27. C.L. Chaffer, and R.A. Weinberg A perspective on cancer cell metastasis Science 331 2011 1559 1564
28. D. Tarin, E.W. Thompson, and D.F. Newgreen The fallacy of epithelial mesenchymal transition in neoplasia Cancer Res 65 2005 5996 6000 discussion 6000-1
29. M. Korpal, B.J. Ell, and F.M. Buffa Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization Nat Med 17 2011 1101 1108
30. G.P. Gupta, J. Perk, and S. Acharyya ID genes mediate tumor reinitiation during breast cancer lung metastasis Proc Natl Acad Sci U S A 104 2007 19506 19511
31. M. Stankic, S. Pavlovic, and Y. Chin TGF-β-Id1 signaling opposes Twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition Cell Rep 5 2013 1228 1242
32. A.D. Goldberg, C.D. Allis, and E. Bernstein Epigenetics: a landscape takes shape Cell 128 2007 635 638
33. S.L. Berger, T. Kouzarides, R. Shiekhattar, and A. Shilatifard An operational definition of epigenetics Genes Dev 23 2009 781 783
34. Y. Huang, S. Nayak, R. Jankowitz, N.E. Davidson, and S. Oesterreich Epigenetics in breast cancer: what's new? Breast Cancer Res 13 2011 225
35. T. Jenuwein, and C.D. Allis Translating the histone code Science 293 2001 1074 1080
36. S. Sharma, T.K. Kelly, and P.A. Jones Epigenetics in cancer Carcinogenesis 31 2010 27 36
37. M.A. Dawson, and T. Kouzarides Cancer epigenetics: from mechanism to therapy Cell 150 2012 12 27
38. M. Berdasco, and M. Esteller Aberrant epigenetic landscape in cancer: how cellular identity goes awry Dev Cell 19 2010 698 711
39. P.A. Jones, and S.B. Baylin The epigenomics of cancer Cell 128 2007 683 692
40. S.C. Stadler, and C.D. Allis Linking epithelial-to-mesenchymal-transition and epigenetic modifications Semin Cancer Biol 22 2012 404 410
41. K. Grønbaek, C. Hother, and P.A. Jones Epigenetic changes in cancer APMIS 115 2007 1039 1059
42. A. Portela, and M. Esteller Epigenetic modifications and human disease Nat Biotechnol 28 2010 1057 1068
43. R. Straussman, D. Nejman, and D. Roberts Developmental programming of CpG island methylation profiles in the human genome Nat Struct Mol Biol 16 2009 564 571
44. S.B. Baylin, and P.A. Jones A decade of exploring the cancer epigenome: biological and translational implications Nat Rev Cancer 11 2011 726 734
45. K.D. Robertson DNA methylation and human disease Nat Rev Genet 6 2005 597 610
46. T.H. Bestor The DNA methyltransferases of mammals Hum Mol Genet 9 2000 2395 2402
47. E. Li, T.H. Bestor, and R. Jaenisch Targeted mutation of the DNA methyltransferase gene results in embryonic lethality Cell 69 1992 915 926
48. M. Okano, D.W. Bell, D.A. Haber, and E. Li DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development Cell 99 1999 247 257
49. X. Nan, F.J. Campoy, and A. Bird MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin Cell 88 1997 471 481
50. P.L. Jones, G.J. Veenstra, and P.A. Wade Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription Nat Genet 19 1998 187 191
51. R.J. Klose, and A.P. Bird Genomic DNA methylation: the mark and its mediators Trends Biochem Sci 31 2006 89 97
52. R.C. Friedman, K.K. Farh, C.B. Burge, and D.P. Bartel Most mammalian mRNAs are conserved targets of microRNAs Genome Res 19 2009 92 105
53. W. Filipowicz, L. Jaskiewicz, F.A. Kolb, and R.S. Pillai Post-transcriptional gene silencing by siRNAs and miRNAs Curr Opin Struct Biol 15 2005 331 341
54. T.J. Ley, L. Ding, and M.J. Walter DNMT3A mutations in acute myeloid leukemia N Engl J Med 363 2010 2424 2433
55. W.M. Rideout, G.A. Coetzee, A.F. Olumi, and P.A. Jones 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes Science 249 1990 1288 1290
56. M.J. Hoffmann, and W.A. Schulz Causes and consequences of DNA hypomethylation in human cancer Biochem Cell Biol 83 2005 296 321
57. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
58. W.M. Grady, J. Willis, and P.J. Guilford Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer Nat Genet 26 2000 16 17
59. C. Stirzaker, D.S. Millar, and C.L. Paul Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors Cancer Res 57 1997 2229 2237
60. J.G. Herman, F. Latif, and Y. Weng Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma Proc Natl Acad Sci U S A 91 1994 9700 9704
61. A. Dobrovic, and D. Simpfendorfer Methylation of the BRCA1 gene in sporadic breast cancer Cancer Res 57 1997 3347 3350
62. D. Luo, B. Zhang, and L. Lv Methylation of CpG islands of p16 associated with progression of primary gastric carcinomas Lab Invest 86 2006 591 598
63. A. Doi, I. Park, and B. Wen Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts Nat Genet 41 2009 1350 1353
64. A. Meissner, T.S. Mikkelsen, and H. Gu Genome-scale DNA methylation maps of pluripotent and differentiated cells Nature 454 2008 766 770
65. G. Ficz, M.R. Branco, and S. Seisenberger Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation Nature 473 2011 398 402
66. M. Tahiliani, K.P. Koh, and Y. Shen Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1 Science 324 2009 930 935
67. K. Williams, J. Christensen, and M.T. Pedersen TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity Nature 473 2011 343 348
68. V.G. Allfrey, R. Faulkner, and A.E. Mirsky Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis Proc Natl Acad Sci U S A 51 1964 786 794
69. V.G. Allfrey, and A.E. Mirsky Structural modifications of histones and their possible role in the regulation of RNA synthesis Science 144 1964 559
70. T. Kouzarides Chromatin modifications and their function Cell 128 2007 693 705
71. G. Liang, Joy CY. Lin, and V. Wei Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome Proc Natl Acad Sci U S A 101 2004 7357 7362
72. T.R. Hebbes, A.W. Thorne, and C. Crane-Robinson A direct link between core histone acetylation and transcriptionally active chromatin EMBO J 7 1988 1395 1402
73. Y. Shi Histone lysine demethylases: emerging roles in development, physiology and disease Nat Rev Genet 8 2007 829 833
74. M. Haberland, R.L. Montgomery, and E.N. Olson The many roles of histone deacetylases in development and physiology: implications for disease and therapy Nat Rev Genet 10 2009 32 42
75. K.E. Gardner, C.D. Allis, and B.D. Strahl Operating on chromatin, a colorful language where context matters J Mol Biol 409 2011 36 46
76. B.D. Strahl, and C.D. Allis The language of covalent histone modifications Nature 403 2000 41 45
77. B.M. Turner Histone acetylation and an epigenetic code Bioessays 22 2000 836 845
78. J. Lee, E. Smith, and A. Shilatifard The language of histone crosstalk Cell 142 2010 682 685
79. G.G. Wang, C.D. Allis, and P. Chi Chromatin remodeling and cancer. Part II: ATP-dependent chromatin remodeling Trends Mol Med 13 2007 373 380
80. G.G. Wang, C.D. Allis, and P. Chi Chromatin remodeling and cancer. Part I: covalent histone modifications Trends Mol Med 13 2007 363 372
81. H. Ozdaʇ, A.E. Teschendorff, and A.A. Ahmed Differential expression of selected histone modifier genes in human solid cancers BMC Genomics 7 2006 90
82. A. Santenard, and M. Torres-Padilla Epigenetic reprogramming in mammalian reproduction: contribution from histone variants Epigenetics 4 2009 80 84
83. K. Sarma, and D. Reinberg Histone variants meet their match Nat Rev Mol Cell Biol 6 2005 139 149
84. C. Jin, and G. Felsenfeld Nucleosome stability mediated by histone variants H3.3 and H2A.Z Genes Dev 21 2007 1519 1529
85. D. Zilberman, D. Coleman-Derr, T. Ballinger, and S. Henikoff Histone H2A.Z and DNA methylation are mutually antagonistic chromatin marks Nature 456 2008 125 129
86. P.W. Lewis, S.J. Elsaesser, K. Noh, S.C. Stadler, and C.D. Allis Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres Proc Natl Acad Sci U S A 107 2010 14075 14080
87. J. Tang, S. Wu, and H. Liu A novel transcription regulatory complex containing death domain-associated protein and the ATR-X syndrome protein J Biol Chem 279 2004 20369 20377
88. Y. Xue, R. Gibbons, and Z. Yan The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies Proc Natl Acad Sci U S A 100 2003 10635 10640
89. C.M. Heaphy, R.F. de Wilde, and Y. Jiao Altered telomeres in tumors with ATRX and DAXX mutations Science 333 2011 425
90. Y. Jiao, C. Shi, and B.H. Edil DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors Science 331 2011 1199 1203
91. J. Schwartzentruber, A. Korshunov, and X. Liu Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma Nature 482 2012 226 231
92. G. Wu, A. Broniscer, and T.A. McEachron Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas Nat Genet 44 2012 251 253
93. P.W. Lewis, M.M. Müller, and M.S. Koletsky Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma Science 340 2013 857 861
94. M.R. Hassler, and G. Egger Epigenomics of cancer: emerging new concepts Biochimie 94 2012 2219 2230
95. P. Carninci, T. Kasukawa, and S. Katayama The transcriptional landscape of the mammalian genome Science 309 2005 1559 1563
96. B.T. Wilhelm, S. Marguerat, and S. Watt Dynamic repertoire of a eukaryotic transcriptome surveyed at single-nucleotide resolution Nature 453 2008 1239 1243
97. P. Bertone, V. Stolc, and T.E. Royce Global identification of human transcribed sequences with genome tiling arrays Science 306 2004 2242 2246
98. P. Kapranov, J. Cheng, and S. Dike RNA maps reveal new RNA classes and a possible function for pervasive transcription Science 316 2007 1484 1488
99. P. Kapranov, A.T. Willingham, and T.R. Gingeras Genome-wide transcription and the implications for genomic organization Nat Rev Genet 8 2007 413 423
100. M. Guttman, and J.L. Rinn Modular regulatory principles of large non-coding RNAs Nature 482 2012 339 346
101. T. Gutschner, and S. Diederichs The hallmarks of cancer: a long non-coding RNA point of view RNA Biol 9 2012 703 719
102. C.H. Li, and Y. Chen Targeting long non-coding RNAs in cancers: progress and prospects Int J Biochem Cell Biol 45 2013 1895 1910
103. R.A. Gupta, N. Shah, and K.C. Wang Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis Nature 464 2010 1071 1076
104. P.G. Maass, F.C. Luft, and S. Bähring Long non-coding RNA in health and disease J Mol Med 92 2014 337 346
105. J.H. Bergmann, and D.L. Spector Long non-coding RNAs: modulators of nuclear structure and function Curr Opin Cell Biol 26 2014 10 18
106. A. Fatica, and I. Bozzoni Long non-coding RNAs: new players in cell differentiation and development Nat Rev Genet 15 2014 7 21
107. S. Geisler, and J. Coller RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts Nat Rev Mol Cell Biol 14 2013 699 712
108. H. Zhang, Z. Chen, X. Wang, Z. Huang, Z. He, and Y. Chen Long non-coding RNA: a new player in cancer J Hematol Oncol 6 2013 37
109. C. Wahlestedt Targeting long non-coding RNA to therapeutically upregulate gene expression Nat Rev Drug Discov 12 2013 433 446
110. L. He, and G.J. Hannon MicroRNAs: small RNAs with a big role in gene regulation Nat Rev Genet 5 2004 522 531
111. S. Deng, G.A. Calin, C.M. Croce, G. Coukos, and L. Zhang Mechanisms of microRNA deregulation in human cancer Cell Cycle 7 2008 2643 2646
112. Y. Saito, and P.A. Jones Epigenetic activation of tumor suppressor microRNAs in human cancer cells Cell Cycle 5 2006 2220 2222
113. S.A. Melo, S. Ropero, and C. Moutinho A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function Nat Genet 41 2009 365 370
114. M. Fabbri, R. Garzon, and A. Cimmino MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B Proc Natl Acad Sci U S A 104 2007 15805 15810
115. J.M. Friedman, P.A. Jones, and G. Liang The tumor suppressor microRNA-101 becomes an epigenetic player by targeting the polycomb group protein EZH2 in cancer Cell Cycle 8 2009 2313 2314
116. J.M. Friedman, G. Liang, and C. Liu The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2 Cancer Res 69 2009 2623 2629
117. M. Korpal, E.S. Lee, G. Hu, and Y. Kang The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2 J Biol Chem 283 2008 14910 14914
118. M.V. Iorio, M. Ferracin, and C. Liu MicroRNA gene expression deregulation in human breast cancer Cancer Res 65 2005 7065 7070
119. M. Han, M. Liu, and Y. Wang Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells Mol Cell Biochem 363 2012 427 436
120. W. Kong, H. Yang, and L. He MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA Mol Cell Biol 28 2008 6773 6784
121. J. Lu, G. Getz, and E.A. Miska MicroRNA expression profiles classify human cancers Nature 435 2005 834 838
122. J.M. Thomson, M. Newman, J.S. Parker, E.M. Morin-Kensicki, T. Wright, and S.M. Hammond Extensive post-transcriptional regulation of microRNAs and its implications for cancer Genes Dev 20 2006 2202 2227
123. A. Ventura, and T. Jacks MicroRNAs and cancer: short RNAs go a long way Cell 136 2009 586 591
124. A. Lujambio, and M. Esteller How epigenetics can explain human metastasis: a new role for microRNAs Cell Cycle 8 2009 377 382
125. P.S. Mongroo, and A.K. Rustgi The role of the miR-200 family in epithelial-mesenchymal transition Cancer Biol Ther 10 2010 219 222
126. Y. Wang, and Y. Shang Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis Exp Cell Res 319 2013 160 169
127. S. Park, A.B. Gaur, E. Lengyel, and M.E. Peter The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 Genes Dev 22 2008 894 907
128. P.A. Gregory, A.G. Bert, and E.L. Paterson The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 Nat Cell Biol 10 2008 593 601
129. G.J. Hurteau, J.A. Carlson, S.D. Spivack, and G.J. Brock Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin Cancer Res 67 2007 7972 7976
130. C.P. Bracken, P.A. Gregory, and N. Kolesnikoff A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition Cancer Res 68 2008 7846 7854
131. H. Peinado, F. Portillo, and A. Cano Transcriptional regulation of cadherins during development and carcinogenesis Int J Dev Biol 48 2004 365 375
132. M. Takeichi Cadherins in cancer: implications for invasion and metastasis Curr Opin Cell Biol 5 1993 806 811
133. W. Birchmeier, and J. Behrens Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness Biochim Biophys Acta 1198 1994 11 26
134. J.R. Graff, J.G. Herman, and R.G. Lapidus E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas Cancer Res 55 1995 5195 5199
135. C.H. Damsky, J. Richa, D. Solter, K. Knudsen, and C.A. Buck Identification and purification of a cell surface glycoprotein mediating intercellular adhesion in embryonic and adult tissue Cell 34 1983 455 466
136. Q. Cao, J. Yu, and S.M. Dhanasekaran Repression of E-cadherin by the polycomb group protein EZH2 in cancer Oncogene 27 2008 7274 7284
137. R. Moll, M. Mitze, U.H. Frixen, and W. Birchmeier Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas Am J Pathol 143 1993 1731 1742
138. H. Oka, H. Shiozaki, and K. Kobayashi Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis Cancer Res 53 1993 1696 1701
139. H. Peinado, D. Olmeda, and A. Cano Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7 2007 415 428
140. G. Berx, K.F. Becker, H. Höfler, and F. van Roy Mutations of the human E-cadherin (CDH1) gene Hum Mutat 12 1998 226 237
141. G. Strathdee Epigenetic versus genetic alterations in the inactivation of E-cadherin Semin Cancer Biol 12 2002 373 379
142. K. Yoshiura, Y. Kanai, A. Ochiai, Y. Shimoyama, T. Sugimura, and S. Hirohashi Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas Proc Natl Acad Sci U S A 92 1995 7416 7419
143. M. Lombaerts, T. van Wezel, and K. Philippo E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines Br J Cancer 94 2006 661 671
144. J.R. Graff, E. Gabrielson, H. Fujii, S.B. Baylin, and J.G. Herman Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression J Biol Chem 275 2000 2727 2732
145. R.A. Hinshelwood, and S.J. Clark Breast cancer epigenetics: normal human mammary epithelial cells as a model system J Mol Med 86 2008 1315 1328
146. M. Widschwendter, and P.A. Jones DNA methylation and breast carcinogenesis Oncogene 21 2002 5462 5482
147. C.J. Sherr Cancer cell cycles Science 274 1996 1672 1677
148. J.G. Herman, A. Merlo, and L. Mao Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers Cancer Res 55 1995 4525 4530
149. E. Evron, C.B. Umbricht, and D. Korz Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation Cancer Res 61 2001 2782 2787
150. J.A. Uría, A.A. Ferrando, G. Velasco, J.M. Freije, and C. López-Otín Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family Cancer Res 54 1994 2091 2094
151. K.E. Bachman, J.G. Herman, and P.G. Corn Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers Cancer Res 59 1999 798 802
152. E. Batlle, E. Sancho, and C. Francí The transcription factor SNAIL is a repressor of E-cadherin gene expression in epithelial tumour cells Nat Cell Biol 2 2000 84 89
153. A. Cano, M.A. Pérez-Moreno, and I. Rodrigo The transcription factor SNAIL controls epithelial-mesenchymal transitions by repressing E-cadherin expression Nat Cell Biol 2 2000 76 83
154. K.M. Hajra, D.Y. Chen, and E.R. Fearon The SLUG zinc-finger protein represses E-cadherin in breast cancer Cancer Res 62 2002 1613 1618
155. A. Eger, K. Aigner, and S. Sonderegger DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells Oncogene 24 2005 2375 2385
156. J. Comijn, G. Berx, and P. Vermassen The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion Mol Cell 7 2001 1267 1278
157. M.A. Perez-Moreno, A. Locascio, and I. Rodrigo A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions J Biol Chem 276 2001 27424 27431
158. I. Castanon, and M.K. Baylies A Twist in fate: evolutionary comparison of Twist structure and function Gene 287 2002 11 22
159. J. Fu, L. Qin, and T. He The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis Cell Res 21 2011 275 289
160. M.J. Blanco, G. Moreno-Bueno, and D. Sarrio Correlation of SNAIL expression with histological grade and lymph node status in breast carcinomas Oncogene 21 2002 3241 3246
161. C.W. Cheng, P.E. Wu, and J.C. Yu Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene Oncogene 20 2001 3814 3823
162. C. Côme, F. Magnino, and F. Bibeau SNAIL and SLUG play distinct roles during breast carcinoma progression Clin Cancer Res 12 2006 5395 5402
163. S. Elloul, M.B. Elstrand, and J.M. Nesland Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma Cancer 103 2005 1631 1643
164. S.E. Moody, D. Perez, and T. Pan The transcriptional repressor Snail promotes mammary tumor recurrence Cancer Cell 8 2005 197 209
165. H. Peinado, E. Ballestar, M. Esteller, and A. Cano Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex Mol Cell Biol 24 2004 306 319
166. C. Dong, Y. Wu, and Y. Wang Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer Oncogene 32 2013 1351 1362
167. M.L. Grooteclaes, and S.M. Frisch Evidence for a function of CtBP in epithelial gene regulation and anoikis Oncogene 19 2000 3823 3828
168. Y. Shi, J. Sawada, and G. Sui Coordinated histone modifications mediated by a CtBP co-repressor complex Nature 422 2003 735 738
169. N. Fujita, D.L. Jaye, M. Kajita, C. Geigerman, C.S. Moreno, and P.A. Wade MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer Cell 113 2003 207 219
170. R. Kumar Another tie that binds the MTA family to breast cancer Cell 113 2003 142 143
171. S.C. Stadler, C.T. Vincent, and V.D. Fedorov Dysregulation of PAD4-mediated citrullination of nuclear GSK3β activates TGF-β signaling and induces epithelial-to-mesenchymal transition in breast cancer cells Proc Natl Acad Sci U S A 110 2013 11851 11856
172. D.P. Satijn, and A.P. Otte Polycomb group protein complexes: do different complexes regulate distinct target genes? Biochim Biophys Acta 1447 1999 1 16
173. H. Chen, S. Tu, and J. Hsieh Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer J Biol Chem 280 2005 22437 22444
174. M. Koyanagi, A. Baguet, J. Martens, R. Margueron, T. Jenuwein, and M. Bix EZH2 and histone 3 trimethyl lysine 27 associated with Il4 and Il13 gene silencing in Th1 cells J Biol Chem 280 2005 31470 31477
175. J. Yu, J. Yu, and D.R. Rhodes A polycomb repression signature in metastatic prostate cancer predicts cancer outcome Cancer Res 67 2007 10657 10663
176. A.P. Bracken, N. Dietrich, D. Pasini, K.H. Hansen, and K. Helin Genome-wide mapping of polycomb target genes unravels their roles in cell fate transitions Genes Dev 20 2006 1123 1136
177. T. Blick, E. Widodo, and H. Hugo Epithelial mesenchymal transition traits in human breast cancer cell lines Clin Exp Metas 25 2008 629 642
178. C. Chang, J. Yang, and W. Xia EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling Cancer Cell 19 2011 86 100
179. K. Collett, G.E. Eide, and J. Arnes Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer Clin Cancer Res 12 2006 1168 1174
180. C.G. Kleer, Q. Cao, and S. Varambally EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells Proc Natl Acad Sci U S A 100 2003 11606 11611
181. N. Herranz, D. Pasini, and V.M. Díaz Polycomb complex 2 is required for E-cadherin repression by the Snail1 transcription factor Mol Cell Biol 28 2008 4772 4781
182. M. Tachibana, K. Sugimoto, and M. Nozaki G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis Genes Dev 16 2002 1779 1791
183. R. Collins, and X. Cheng A case study in cross-talk: the histone lysine methyltransferases G9a and GLP Nucl Acids Res 38 2010 3503 3511
184. C. Dong, Y. Wu, and J. Yao G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer J Clin Invest 122 2012 1469 1486
185. J. Fang, Q. Feng, and C.S. Ketel Purification and functional characterization of SET8, a nucleosomal histone H4-lysine 20-specific methyltransferase Curr Biol 12 2002 1086 1099
186. K. Nishioka, J.C. Rice, and K. Sarma PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is associated with silent chromatin Mol Cell 9 2002 1201 1213
187. N. Kalakonda, W. Fischle, and P. Boccuni Histone H4 lysine 20 monomethylation promotes transcriptional repression by L3MBTL1 Oncogene 27 2008 4293 4304
188. H. Talasz, H.H. Lindner, B. Sarg, and W. Helliger Histone H4-lysine 20 monomethylation is increased in promoter and coding regions of active genes and correlates with hyperacetylation J Biol Chem 280 2005 38814 38822
189. F. Yang, L. Sun, and Q. Li SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities EMBO J 31 2012 110 123
190. Y. Xiang, Z. Zhu, and G. Han JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer Proc Natl Acad Sci U S A 104 2007 19226 19231
191. A. Roesch, B. Becker, and S. Meyer Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas Mod Pathol 18 2005 1249 1257
192. S. Hayami, M. Yoshimatsu, and A. Veerakumarasivam Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway Mol Cancer 9 2010 59
193. P.J. Lu, K. Sundquist, and D. Baeckstrom A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer J Biol Chem 274 1999 15633 15645
194. A. Barrett, B. Madsen, and J. Copier PLU-1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues: a new cancer/testis antigen? Int J Cancer 101 2002 581 588
195. K. Yamane, K. Tateishi, and R.J. Klose PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation Mol Cell 25 2007 801 812
196. D. Mitra, P.M. Das, F.C. Huynh, and F.E. Jones Jumonji/ARID1 B (JARID1B) protein promotes breast tumor cell cycle progression through epigenetic repression of microRNA let-7e J Biol Chem 286 2011 40531 40535
197. Y. Shi, F. Lan, and C. Matson Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 Cell 119 2004 941 953
198. S. Lim, A. Janzer, and A. Becker Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology Carcinogenesis 31 2010 512 520
199. S. Hayami, J.D. Kelly, and H. Cho Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers Int J Cancer 128 2011 574 586
200. Y. Wu, Y. Wang, and X.H. Yang The deubiquitinase USP28 stabilizes LSD1 and confers stem-cell-like traits to breast cancer cells Cell Rep 5 2013 224 236
201. J.K. Tong, C.A. Hassig, G.R. Schnitzler, R.E. Kingston, and S.L. Schreiber Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex Nature 395 1998 917 921
202. A. You, J.K. Tong, C.M. Grozinger, and S.L. Schreiber CoREST is an integral component of the CoREST-human histone deacetylase complex Proc Natl Acad Sci U S A 98 2001 1454 1458
203. T.B. Nicholson, and T. Chen LSD1 demethylates histone and non-histone proteins Epigenetics 4 2009 129 132
204. Y. Wang, H. Zhang, and Y. Chen LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer Cell 138 2009 660 672
205. T. Lin, A. Ponn, X. Hu, B.K. Law, and J. Lu Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition Oncogene 29 2010 4896 4904
206. E. Metzger, M. Wissmann, and N. Yin LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription Nature 437 2005 436 439
207. R.G. Lapidus, S.J. Nass, and N.E. Davidson The loss of estrogen and progesterone receptor gene expression in human breast cancer J Mamm Gland Biol Neoplasia 3 1998 85 94
208. J. Caldeira, F. Roberto, and E.C. Prando CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer BMC Cancer 6 2006 48
209. S.J. Nass, J.G. Herman, and E. Gabrielson Aberrant methylation of the estrogen receptor and E-cadherin 5′ CpG islands increases with malignant progression in human breast cancer Cancer Res 60 2000 4346 4348
210. A.T. Ferguson, R.G. Lapidus, S.B. Baylin, and N.E. Davidson Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression Cancer Res 55 1995 2279 2283
211. X. Yang, D.L. Phillips, A.T. Ferguson, W.G. Nelson, J.G. Herman, and N.E. Davidson Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells Cancer Res 61 2001 7025 7029
212. L. Yan, S.J. Nass, D. Smith, W.G. Nelson, J.G. Herman, and N.E. Davidson Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines Cancer Biol Ther 2 2003 552 556
213. X. Yang, A.T. Ferguson, and S.J. Nass Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition Cancer Res 60 2000 6890 6894
214. J.C. Keen, L. Yan, and K.M. Mack A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2′-deoxycytidine Breast Cancer Res Treat 81 2003 177 186
215. S.A. Mullany, M. Moslemi-Kebria, and R. Rattan Expression and functional significance of HtrA1 loss in endometrial cancer Clin Cancer Res 17 2011 427 436
216. J. Narkiewicz, S. Lapinska-Szumczyk, D. Zurawa-Janicka, J. Skorko-Glonek, J. Emerich, and B. Lipinska Expression of human HtrA1, HtrA2, HtrA3 and TGF-beta1 genes in primary endometrial cancer Oncol Rep 21 2009 1529 1537
217. J. Chien, J. Staub, and S. Hu A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer Oncogene 23 2004 1636 1644
218. N. Wang, K.A. Eckert, and A.R. Zomorrodi Down-regulation of HtrA1 activates the epithelial-mesenchymal transition and ATM DNA damage response pathways PLoS One 7 2012 e39446
219. A. Lehner, V. Magdolen, and T. Schuster Downregulation of serine protease HTRA1 is associated with poor survival in breast cancer PLoS One 8 2013 e60359
220. H. Kaur, S. Mao, and Q. Li RNA-Seq of human breast ductal carcinoma in situ models reveals aldehyde dehydrogenase isoform 5A1 as a novel potential target PLoS One 7 2012 e50249
221. U. Burk, J. Schubert, and U. Wellner A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells EMBO Rep 9 2008 582 589
222. P.A. Gregory, C.P. Bracken, A.G. Bert, and G.J. Goodall MicroRNAs as regulators of epithelial-mesenchymal transition Cell Cycle 7 2008 3112 3118
223. V. Davalos, C. Moutinho, and A. Villanueva Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis Oncogene 31 2012 2062 2074
224. S.O. Suh, Y. Chen, and M.S. Zaman MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer Carcinogenesis 32 2011 772 778
225. M. Sachdeva, and Y. Mo miR-145-mediated suppression of cell growth, invasion and metastasis Am J Transl Res 2 2010 170 180
226. B. Shi, L. Sepp-Lorenzino, M. Prisco, P. Linsley, T. deAngelis, and R. Baserga Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells J Biol Chem 282 2007 32582 32590
227. M. Sachdeva, S. Zhu, and F. Wu p53 represses c-Myc through induction of the tumor suppressor miR-145 Proc Natl Acad Sci U S A 106 2009 3207 3212
228. A. Lujambio, G.A. Calin, and A. Villanueva A microRNA DNA methylation signature for human cancer metastasis Proc Natl Acad Sci U S A 105 2008 13556 13561
229. P. Lopez-Serra, and M. Esteller DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer Oncogene 31 2012 1609 1622
230. G. Martello, A. Rosato, and F. Ferrari A microRNA targeting dicer for metastasis control Cell 141 2010 1195 1207
231. L. Ma, J. Teruya-Feldstein, and R.A. Weinberg Tumour invasion and metastasis initiated by microRNA-10b in breast cancer Nature 449 2007 682 688
232. L. Ma, J. Young, and H. Prabhala miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis Nat Cell Biol 12 2010 247 256
233. I.A. Asangani, S.A.K. Rasheed, and D.A. Nikolova MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer Oncogene 27 2008 2128 2136
234. S. Zhu, M. Si, H. Wu, and Y. Mo MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1) J Biol Chem 282 2007 14328 14336
235. B. Song, C. Wang, and J. Liu MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression J Exp Clin Cancer Res 29 2010 29
236. T.K. Kelly, D.D. De Carvalho, and P.A. Jones Epigenetic modifications as therapeutic targets Nat Biotechnol 28 2010 1069 1078
237. C.B. Yoo, and P.A. Jones Epigenetic therapy of cancer: past, present and future Nat Rev Drug Discov 5 2006 37 50
238. E. Kaminskas, A. Farrell, and S. Abraham Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypes Clin Cancer Res 11 2005 3604 3608
239. R.W. Johnstone, and J.D. Licht Histone deacetylase inhibitors in cancer therapy: is transcription the primary target? Cancer Cell 4 2003 13 18
240. M. Federico, and L. Bagella Histone deacetylase inhibitors in the treatment of hematological malignancies and solid tumors J Biomed Biotechnol 2011 2011 475641
241. R.L. Piekarz, R. Frye, and M. Turner Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma J Clin Oncol 27 2009 5410 5417
242. E.A. Olsen, Y.H. Kim, and T.M. Kuzel Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma J Clin Oncol 25 2007 3109 3115
243. M. Bantscheff, C. Hopf, and M.M. Savitski Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes Nat Biotechnol 29 2011 255 265
244. S.A. Belinsky, D.M. Klinge, and C.A. Stidley Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer Cancer Res 63 2003 7089 7093
245. J. Tan, X. Yang, and L. Zhuang Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells Genes Dev 21 2007 1050 1063
246. Y. Huang, E. Greene, and T. Murray Stewart Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes Proc Natl Acad Sci U S A 104 2007 8023 8028
247. Y. Huang, T.M. Stewart, and Y. Wu Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genes Clin Cancer Res 15 2009 7217 7228
248. J.E. Delmore, G.C. Issa, and M.E. Lemieux BET bromodomain inhibition as a therapeutic strategy to target c-Myc Cell 146 2011 904 917
249. P. Filippakopoulos, J. Qi, and S. Picaud Selective inhibition of BET bromodomains Nature 468 2010 1067 1073
250. J.A. Mertz, A.R. Conery, and B.M. Bryant Targeting MYC dependence in cancer by inhibiting BET bromodomains Proc Natl Acad Sci U S A 108 2011 16669 16674
251. B.E. Schwartz, M.D. Hofer, and M.E. Lemieux Differentiation of NUT midline carcinoma by epigenomic reprogramming Cancer Res 71 2011 2686 2696
252. J. Zuber, J. Shi, and E. Wang RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia Nature 478 2011 524 528
253. M.V. Iorio, P. Casalini, C. Piovan, L. Braccioli, and E. Tagliabue Breast cancer and microRNAs: therapeutic impact Breast 20 Suppl3 2011 63 70
254. P. Trang, J.F. Wiggins, and C.L. Daige Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice Mol Ther 19 2011 1116 1122
255. L. Ma, F. Reinhardt, and E. Pan Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model Nat Biotechnol 28 2010 341 347